Anagnostopoulos A - Search Results

1

Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation.

Politou MC, Heath DJ, Rahemtulla A, Szydlo R, Anagnostopoulos A, Dimopoulos MA, Croucher PI, Terpos E. Politou MC, et al. Among authors: anagnostopoulos a. Int J Cancer. 2006 Oct 1;119(7):1728-31. doi: 10.1002/ijc.22033. Int J Cancer. 2006. PMID: 16646053 Free article.

2

Autologous and allogeneic stem cell transplantation in Waldenstrom's macroglobulinemia: review of the literature and future directions.

Anagnostopoulos A, Aleman A, Giralt S. Anagnostopoulos A, et al. Semin Oncol. 2003 Apr;30(2):286-90. doi: 10.1053/sonc.2003.50052. Semin Oncol. 2003. PMID: 12720154 Review.

3

Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS).

Politou M, Terpos E, Anagnostopoulos A, Szydlo R, Laffan M, Layton M, Apperley JF, Dimopoulos MA, Rahemtulla A. Politou M, et al. Among authors: anagnostopoulos a. Br J Haematol. 2004 Sep;126(5):686-9. doi: 10.1111/j.1365-2141.2004.05092.x. Br J Haematol. 2004. PMID: 15327520

4

Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma.

Terpos E, Heath DJ, Rahemtulla A, Zervas K, Chantry A, Anagnostopoulos A, Pouli A, Katodritou E, Verrou E, Vervessou EC, Dimopoulos MA, Croucher PI. Terpos E, et al. Among authors: anagnostopoulos a. Br J Haematol. 2006 Dec;135(5):688-92. doi: 10.1111/j.1365-2141.2006.06356.x. Br J Haematol. 2006. PMID: 17107351

5

Extent of damage and repair in the p53 tumor-suppressor gene after treatment of myeloma patients with high-dose melphalan and autologous blood stem-cell transplantation is individualized and may predict clinical outcome.

Dimopoulos MA, Souliotis VL, Anagnostopoulos A, Papadimitriou C, Sfikakis PP. Dimopoulos MA, et al. Among authors: anagnostopoulos a. J Clin Oncol. 2005 Jul 1;23(19):4381-9. doi: 10.1200/JCO.2005.07.385. Epub 2005 May 9. J Clin Oncol. 2005. PMID: 15883412

6

Melphalan-induced DNA damage in vitro as a predictor for clinical outcome in multiple myeloma.

Dimopoulos MA, Souliotis VL, Anagnostopoulos A, Bamia C, Pouli A, Baltadakis I, Terpos E, Kyrtopoulos SA, Sfikakis PP. Dimopoulos MA, et al. Among authors: anagnostopoulos a. Haematologica. 2007 Nov;92(11):1505-12. doi: 10.3324/haematol.11435. Haematologica. 2007. PMID: 18024399 Free article. Clinical Trial.

7

Multiple myeloma in elderly patients: prognostic factors and outcome.

Anagnostopoulos A, Gika D, Symeonidis A, Zervas K, Pouli A, Repoussis P, Grigoraki V, Anagnostopoulos N, Economopoulos T, Maniatis A, Dimopoulos MA. Anagnostopoulos A, et al. Among authors: anagnostopoulos n. Eur J Haematol. 2005 Nov;75(5):370-5. doi: 10.1111/j.1600-0609.2005.00532.x. Eur J Haematol. 2005. PMID: 16191085

8

Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma.

Anagnostopoulos A, Aleman A, Ayers G, Donato M, Champlin R, Weber D, Alexanian R, Giralt S. Anagnostopoulos A, et al. Cancer. 2004 Jun 15;100(12):2607-12. doi: 10.1002/cncr.20294. Cancer. 2004. PMID: 15197803 Free article.

9

Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy.

Anagnostopoulos A, Aleman A, Yang Y, Donato M, Weber D, Champlin R, Smith T, Alexanian R, Giralt S. Anagnostopoulos A, et al. Bone Marrow Transplant. 2004 Mar;33(6):623-8. doi: 10.1038/sj.bmt.1704398. Bone Marrow Transplant. 2004. PMID: 14730336

10

Macrofocal multiple myeloma in young patients: a distinct entity with favorable prognosis.

Dimopoulos MA, Pouli A, Anagnostopoulos A, Repoussis P, Symeonidis A, Terpos E, Delimbasi S, Tsolakis F, Economopoulos T, Zervas C. Dimopoulos MA, et al. Among authors: anagnostopoulos a. Leuk Lymphoma. 2006 Aug;47(8):1553-6. doi: 10.1080/10428190600647723. Leuk Lymphoma. 2006. PMID: 16966266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results